{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:15:20Z","timestamp":1783318520378,"version":"3.54.6"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate HIV diagnosis is critical to achieving global targets for ending the AIDS epidemic. Despite international recommendations, HIV confirmatory testing in Italy remains poorly standardized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate current HIV confirmation algorithms used in public laboratories across three Italian regions and suggest improvements for harmonization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Within the PRONTI project, we surveyed 31 second-level HIV laboratories in Piemonte, Toscana, and Puglia, representing 20% of the Italian population. Laboratory directors were interviewed using a structured questionnaire on first line and confirmatory assays, algorithm steps, and use of immunoblots (IB) and HIV-RNA testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All laboratories employed 4th-generation Ag\/Ab immunoassays for initial screening. Four confirmatory algorithms were identified: (1) IB followed by HIV-RNA if IB negative\/indeterminate (42%); (2) repeat 4th-generation assay, then IB and HIV-RNA if needed (36%); (3) direct HIV-RNA testing (16%); and (4) HIV-RNA followed by IB if RNA negative\/inconclusive (6%). IB was used in all laboratories in different ways, and HIV-RNA testing in 87% of laboratories. Algorithms varied significantly by region, reflecting decentralized healthcare governance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HIV confirmation practices in Italy remain heterogeneous, with frequent reliance on IB despite recent international trends favoring molecular approaches. Algorithms prioritizing HIV-RNA testing offer faster results, reduce patient anxiety, limit HIV transmission and improve linkage to care, though IB remains useful in selected cases. National guidelines are urgently needed to standardize HIV diagnostic workflows and optimize resource use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1775039","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:38:17Z","timestamp":1783316297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Different approaches to HIV confirmation: a survey of three Italian regions"],"prefix":"10.3389","volume":"16","author":[{"given":"Claudio","family":"Galli","sequence":"first","affiliation":[{"name":"Independent researcher","place":["Roma, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Regine","sequence":"additional","affiliation":[{"name":"National AIDS Unit, Department of Infectious Diseases, Italian National Institute of Health","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Caraglia","sequence":"additional","affiliation":[{"name":"Former General Directorate of Health Prevention, Ministry of Health","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Centrone","sequence":"additional","affiliation":[{"name":"Hygiene Unit, Policlinico Hospital of Bari","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chironna","sequence":"additional","affiliation":[{"name":"Hygiene Section, Interdisciplinary Department of Medicine, University of Bari","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Cruschelli","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Farinella","sequence":"additional","affiliation":[{"name":"Mario Mieli, LGBTQIA+ Culture Center","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Moriconi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Annachiara","family":"Orlando","sequence":"additional","affiliation":[{"name":"Hygiene Section, Interdisciplinary Department of Medicine, University of Bari","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pasqualini","sequence":"additional","affiliation":[{"name":"Piedmont Regional Service for the Epidemiology of Infectious Diseases (SeREMI)","place":["Alessandria, Italy"]},{"name":"Research and Innovation Department (DAIRI), \u201cSS Antonio e Biagio e C. Arrigo\u201d University Hospital","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Puglia","sequence":"additional","affiliation":[{"name":"Tuscany Regional Health Agency (Agenzia Regionale di Sanit\u00e0, ARS)","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pugliese","sequence":"additional","affiliation":[{"name":"National AIDS Unit, Department of Infectious Diseases, Italian National Institute of Health","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rancilio","sequence":"additional","affiliation":[{"name":"Caritas Ambrosiana","place":["Milano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Tavoschi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Voller","sequence":"additional","affiliation":[{"name":"Tuscany Regional Health Agency (Agenzia Regionale di Sanit\u00e0, ARS)","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Suligoi","sequence":"additional","affiliation":[{"name":"National AIDS Unit, Department of Infectious Diseases, Italian National Institute of Health","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"408.e1","DOI":"10.1016\/j.ajog.2018.06.008","article-title":"Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag\/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy","volume":"19","author":"Adhikari","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1128\/CVI.00053-16","article-title":"Human immunodeficiency virus diagnostic testing: 30 years of evolution","volume":"23","author":"Alexander","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"B3","article-title":"Percorso diagnostico \u201cInfezioni da HIV\u201d\u2013Rif. 2023-03, rev. 2023","volume-title":"Italian association for clinical microbiology","year":"2023"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107222","article-title":"Suppressed HIV antibody responses following exposure to antiretrovirals-evidence from PrEP randomized trials and early antiretroviral treatment initiation studies","volume":"148","author":"Avelino-Silva","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01273-25","article-title":"HIV serologic reactivity varies with time of ART initiation in persons on long-term ART","volume":"64","author":"Avelino-Silva","year":"2026","journal-title":"J. Clin. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcv.2018.06.017","article-title":"Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm","volume":"106","author":"Avidor","year":"2018","journal-title":"J. Clin. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcv.2019.02.004","article-title":"Risk stratification of HIV infection for patients needing molecular confirmation with the Abbott 4th generation Architect System","volume":"113","author":"Baltaro","year":"2019","journal-title":"J. Clin. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barr\u00e9-Sinoussi","year":"1983","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.idc.2019.04.001","article-title":"HIV diagnostics. Current recommendations and opportunities for improvement","volume":"33","author":"Branson","year":"2019","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"B10","article-title":"Adult HIV testing guidelines 2020","volume-title":"BHIVA","year":"2020"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/e364152004-001","article-title":"Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections","volume":"38","year":"1989","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B12","unstructured":"Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 update clinical practice guideline\n          \n          \n          \n          2021"},{"key":"B13","unstructured":"Quick reference guide: Recommended laboratory HIV testing algorithm for serum or plasma specimens\n          \n          \n          \n          2018"},{"key":"B14","unstructured":"Pr\u00e9vention et d\u00e9pistage de l\u2019infection VIH\n          \n          \n          \n          2024"},{"key":"B15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/infdis\/jix297","article-title":"Assessment of HIV screening tests for use in preexposure prophylaxis programs","volume":"216","author":"Delaugerre","year":"2017","journal-title":"J. Inf. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/QAI.0b013e3181ab61e1","article-title":"Detection of individuals with acute HIV-1 infection using the ARCHITECT\u00ae HIV Ag\/Ab Combo assay","volume":"52","author":"Eshleman","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B17","unstructured":"HIV\/AIDS Surveillance in Europe 2025\u20132024 data\n          \n          \n          \n          2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13030655","article-title":"Outpatient testing for HIV in Italy 2018\u20132023 - Preliminary data","volume":"13","author":"Galli","year":"2025","journal-title":"Microorganisms"},{"key":"B20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.6601823","article-title":"Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Gallo","year":"1983","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/QAD.0000000000001982","article-title":"p24 revisited: A landscape review of antigen detection for early HIV diagnosis","volume":"32","author":"Gray","year":"2018","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19400","article-title":"Evaluation of a two-test algorithm for HIV screening in a low-prevalence setting and the indications for optimizing clinical management","volume":"9","author":"Huang","year":"2023","journal-title":"Heliyon"},{"key":"B23","first-page":"5","article-title":"Law 135, 5th june, (1990). Programma di (Rome, Italy) interventi urgenti per la prevenzione e la lotta contro l'AIDS","volume":"132","year":"1990","journal-title":"Gazz. Uff"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad629","article-title":"Reflex human immunodeficiency virus (HIV) type 1 RNA testing enables timely differentiation of false-positive results from acute HIV infection","volume":"12","author":"Kaperak","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198924","article-title":"Comparative evaluation of the Geenius HIV 1\/2 confirmatory assay and the HIV-1 and HIV-2 Western blots in the Japanese population","volume":"13","author":"Kondo","year":"2018","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26421","article-title":"Characterizing HIV seroconversions among a cohort of oral PrEP users in South Africa","volume":"28","author":"Martin","year":"2025","journal-title":"J. Int. AIDS Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcv.2018.11.005","article-title":"A multicentre evaluation of the Elecsys\u00ae HIV Duo assay","volume":"112","author":"Muhlbacher","year":"2019","journal-title":"J. Clin. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1136\/sextrans-icar-2025.4","article-title":"Progresses in the continuum of care of people living with HIV, using surveillance and cohort data. Italy 2012-2023","volume":"101","author":"Navarra","year":"2025","journal-title":"Sex Transm. Infect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/JCM.02196-07","article-title":"Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States","volume":"46","author":"Owen","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2019.04.002","article-title":"BioRad BioPlex\u00ae HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm","volume":"116","author":"Parker","year":"2019","journal-title":"J. Clin. Virol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01173-25","article-title":"Performance of national HIV testing algorithms in 14 population-based HIV impact assessment surveys: Accuracy of HIV diagnosis using a two-test strategy, with or without a tie-breaker test, in different prevalence settings 2015-2022","volume":"63","author":"Patel","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/archinternmed.2009.445","article-title":"Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA 2006-2008","volume":"170","author":"Patel","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/cid\/ciaf025","article-title":"Estimating the economic consequences of leveraging the novel cobas HIV-1\/HIV-2 qualitative nucleic acid amplification test in routine HIV testing","volume":"81","author":"Pinar Bilir","year":"2025","journal-title":"Clin. Inf. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/OLQ.0000000000001124","article-title":"Performance of an alternative laboratory-based HIV diagnostic testing algorithm using HIV-1 RNA viral load","volume":"47","author":"Pitasi","year":"2020","journal-title":"Sex Transm. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1515\/CCLM.2006.123","article-title":"Errors in clinical laboratories or errors in laboratory medicine","volume":"44","author":"Plebani","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/clinchem\/37.10.1700","article-title":"Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides","volume":"37","author":"Pollet","year":"1991","journal-title":"Clin. Chem."},{"key":"B37","first-page":"3","article-title":"Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2024","volume":"38","author":"Regine","year":"2025","journal-title":"Not. Ist. Sup. Sanit."},{"key":"B38","first-page":"3","article-title":"HIV-infektion\/AIDS: RKI-ratgeber","volume-title":"Epidemiologisches bulletin","year":"2022"},{"key":"B39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1128\/JCM.02460-13","article-title":"Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody","volume":"52","author":"Salmona","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B40","unstructured":"Diagn\u00f3stico microbiol\u00f3gico de la infecci\u00f3n por el VIH\n          \n          \n          \n          2014"},{"key":"B41","article-title":"HIV testing guidelines 2025. Version 3, 03.09.2025","year":"2025"},{"key":"B42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0166-0934(87)90034-6","article-title":"An improved immunoblotting procedure for the detection of antibodies against HIV","volume":"16","author":"Thorpe","year":"1987","journal-title":"J. Virol. Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1046\/j.1537-2995.1997.37997454018.x","article-title":"Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1\/2 combination enzyme immunoassay screening","volume":"37","author":"Tobler","year":"1997","journal-title":"Transfusion."},{"key":"B44","article-title":"UNAIDS global AIDS update, (2023)","year":"2023","journal-title":"Geneva: joint united nations programme on HIV\/AIDS"},{"key":"B45","unstructured":"Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products. Guidance for industry\n          \n          \n          \n          2023"},{"key":"B46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.annemergmed.2017.11.027","article-title":"Acute HIV discovered during routine HIV screening with HIV antigen-antibody combination tests in 9 US emergency departments","volume":"72","author":"White","year":"2018","journal-title":"Ann. Emerg. Med."},{"key":"B47","article-title":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach; Licence: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland 2021","year":"2021"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/qai.0000000000001665","article-title":"Positive or not, that is the question: HIV testing for individuals on pre-exposure prophylaxis","volume":"78","author":"Zucker","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1775039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:38:23Z","timestamp":1783316303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1775039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":48,"alternative-id":["10.3389\/fcimb.2026.1775039"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1775039","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1775039"}}